Researchers review the latest developments, challenges, and ongoing research in posttransplant maintenance for acute ... who have AML is posttransplant relapse, ranging from 40% to 70%, with ...

Vanda Pharmaceuticals announced results from the long-term maintenance REPRIEVE (Relapse prevention study in patients with schizophrenia) clinical study with Fanapt (iloperidone). The REPRIEVE ...

Additionally, studies of preemptive azacitidine maintenance therapy after transplant demonstrated a delay in hematologic relapse but did not show a survival benefit in a randomized setting.

We conducted a search using MEDLINE/PubMed, the Cochrane library and PsycINFO (last search date January 2011) for randomized, controlled trials of relapse prevention or maintenance treatment of ...

About Study 304 This study was a multicenter, multi-national, randomized, double-blind, placebo-controlled, parallel group study of lumateperone for the prevention of symptomatic relapse in adult ...